“A twice-yearly PrEP choice could overcome challenges with respect to adherence and result in substantial protection against HIV infection for women worldwide,” the study authors wrot ...

Twice-yearly shots ... for HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect against infection. The results in women were published ...

At the beginning of last summer, a trial conducted on 5,000 adolescents and young women in the most HIV ... against infection, although he notes that a dosing regimen of two 'shots' a year also ...

There were no infections in the young women and girls that got the shots ... HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect ...

When it came to innovations in biotech, there was a clear winner: lenacapavir, a drug that was found to prevent HIV infections in 100% of the women and ... effective at protecting people from ...

In a randomized trial involving more than 5,000 young women and girls in South Africa and Uganda, none of those who received the prevention shots contracted HIV. The results were published in the ...

This annual shot might protect against HIV infections Every ... a drug that was found to prevent HIV infections in 100% of the women and girls who received it in a clinical trial.

There were no infections in the young women and girls that got the shots ... HIV. The company said it is waiting for results of testing in men before seeking permission to use it to protect ...